drugset / Trial / NCT00420810

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

NCT00420810

Phase 3 Terminated 138 enrolled H. Lundbeck A/S
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is determine whether this drug will improve your insomnia in terms of decreasing your time to fall asleep and allowing you to stay asleep longer. The drug will be compared against placebo in order to determine if there's a difference.

Timeline

Start
2006-09
Primary completion
2007-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject gaboxadol Small molecule 15 mg

Indications